|Former Common name||FLS-ob|
|H-2 Haplotype||No Data|
|Strain description||No Data|
|Common name||No Data|
|Symbol description||No Data|
|References||Molecular Medicine., 36, 448-451 (1999).
Gastroenterology. 2003 May;124(5):1325-36.
|Research applications||Cancer Research,
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
The RECIPIENT must inform the DEPOSITOR (email@example.com) the research plan using the BIOLOGICAL RESOURCE and must obtain a prior written consent from the DEPOSITOR using the APPROVAL FROM specified by the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, the RECIPIENT must inform the DEPOSITOR of the contents of such publication in advance. The RECIPIENT must contact and discuss with the DEPOSITOR in case of filing a patent application based on research results by using the BIOLOGICAL RESOURCES. The RECIPIENT must contact and discuss with the DEPOSITOR in case of application for any commercial use.
|1||Please contact “firstname.lastname@example.org” to obtain the specific application form for the research plan.|
|2||Genotyping protocol <PCR>|
|Depositor||Shionogi & Co., Ltd.|
|Strain Status /